01 January 2008
Pharmacokinetics of mycophenolic acid and its phenyl-glucuronide in kidney transplant recipients with renal insufï¬ciency
M. Chrzanowska, J. Kamińska, M. Głyda, N. WachowiakAnn Transplant 2008; 13(1): 40-40 :: ID: 880204
Abstract
Background: The aim of the study was to analyze the influence of renal insufficiency on the pharmacokinetics of mycophenolic acid (MPA) and its glucuronide metabolite (MPAG) in kidney transplant patients.
Material/Methods: The study included 43 adult patients at least one year after renal transplantation (from 1 to 11 years), treated with mycophenolate mofetil (MMF) and tacrolimus or cyclosporine and steroids. They were divided into a group with normal renal function (n=16; creatinine clearance [Cl[sub]cr[/sub]] >60 ml/min) and one with renal insufficiency (n=27, Cl[sub]cr[/sub]<60 ml/min). Areas under the 4-hour curve (AUC[sub]0-4h[/sub]) of MPA and MPAG were determined using a validated HPLC method.
Results: The renal insuffi ciency group showed significantly increased AUC[sub]0-4[/sub] and trough levels for MPAG (543.1±366.1 vs. 273.9±113.2 mg-h/ml, p=0.002, and 106.0±78.5 vs. 42.8±22.5 mg/ml, p=0.0002, respectively) and increased trough level of MPA (p=0.01). There was a significant correlation between MPAG AUC[sub]0-4[/sub] or C[sub]0[/sub] and Cl[sub]cr[/sub] (r=±0.592, p<0.00001 and r=-0.698, p<0.00001, respectively). There was no significant difference in MPA AUC[sub]0-4 [/sub]between the renal insufficiency and the normal renal function groups.
Conclusions: Although MPAG is an inactive metabolite, its accumulation in patients with renal impairment can be unfavorable. MPAG has been shown to displace MPA from protein binding sites increasing MPA free fraction without changing total MPA AUC. This should be taken into account when deciding upon MMF dose in patients with renal failure with unexpected side effects.
Keywords: Pharmacokinetics, Mycophenolic Acid, renal transplantation, Tacrolimus
In Press
07 Mar 2024 : Original article
Outcomes of Renal Transplantation in ANCA-Associated VasculitisAnn Transplant In Press; DOI: 10.12659/AOT.943433
08 Mar 2024 : Original article
Association of Coronary Calcium Score on Cardiac PET During Pre-Kidney Transplant Assessment with Persisten...Ann Transplant In Press; DOI: 10.12659/AOT.943532
14 Mar 2024 : Original article
Impact of Blood Products Transfusion on Patients in the Immediate Post-Lung Transplant Period: A Cohort StudyAnn Transplant In Press; DOI: 10.12659/AOT.943652
14 Mar 2024 : Case report
Treatment of Cavernous Transformation of Portal Vein Caused by Hepatic Cystic Echinococcosis Using Ex Vivo ...Ann Transplant In Press; DOI: 10.12659/AOT.942358
Most Viewed Current Articles
05 Apr 2022 : Original article
Impact of Statins on Hepatocellular Carcinoma Recurrence After Living-Donor Liver TransplantationDOI :10.12659/AOT.935604
Ann Transplant 2022; 27:e935604
12 Jan 2022 : Original article
Risk Factors for Developing BK Virus-Associated Nephropathy: A Single-Center Retrospective Cohort Study of ...DOI :10.12659/AOT.934738
Ann Transplant 2022; 27:e934738
22 Nov 2022 : Original article
Long-Term Effects of Everolimus-Facilitated Tacrolimus Reduction in Living-Donor Liver Transplant Recipient...DOI :10.12659/AOT.937988
Ann Transplant 2022; 27:e937988
15 Mar 2022 : Case report
Combined Liver, Pancreas-Duodenum, and Kidney Transplantation for Patients with Hepatitis B Cirrhosis, Urem...DOI :10.12659/AOT.935860
Ann Transplant 2022; 27:e935860